The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Bone Biologics Corp (BBLG) Annual Income Statement (USD)
BBLG Quarterly Financials (USD)
Frequently Asked Questions About Bone Biologics Corp (BBLG) Stock
Bone Biologics Corp's (BBLG) last reported annual revenue was USD 0.00.
Bone Biologics Corp's (BBLG) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Bone Biologics Corp's(BBLG) is not profitable as of its last reported annual financials.
The net profit margin for Bone Biologics Corp's(BBLG) from its laster reported year is N/A
The return on equity (ROE) for Bone Biologics Corp's(BBLG) from its last reported annual financials is : -119.03%
The return on assets (ROA) for Bone Biologics Corp's(BBLG) from its last reported annual financials is : -57.25%
The return on invested capital (ROIC) for Bone Biologics Corp's(BBLG) from its last reported annual financials is : -212.77%
The Debt to Equity ratio for Bone Biologics Corp's(BBLG) from its last reported annual financials is : 0.00%
The dividend yield for Bone Biologics Corp's(BBLG) from its laster reported year is 0.00%
Bone Biologics Corp's(BBLG) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BBLG !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
